Lupin reported INR19.57B in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Bharat Petroleum INR -40.55B 125.98B Jun/2026
Cipla INR 13.88B 154.2M Sep/2026
Divis Laboratories Ltd INR 15.66B 3.04B Sep/2026
Dr.Reddys Laboratories INR 8.6B 2.14B Jun/2026
Sun Pharmaceuticals INR 47.44B 3.26B Sep/2026
UPL INR 22B 7.5B Sep/2026